LYZ and cancer: Changes in lysozyme levels can indicate pathological conditions; for example, monitoring lysozyme levels allows differentiation between acute myelogenous or monocyte leukaemia and acute lymphatic leukaemia, and a tracking response to treatments in cancer patients.